Results 241 to 250 of about 600,341 (272)
Some of the next articles are maybe not open access.

GFLearn: Generalized Feature Learning for Drug-Target Binding Affinity Prediction

IEEE Journal of Biomedical and Health Informatics
Predicting drug-target binding affinity is critical for drug discovery, as it helps identify promising drug candidates and predict their effectiveness. Recent advancements in deep learning have made significant progress in tackling this task. However, existing methods heavily rely on training data, and their performance is often limited when predicting
Zibo Huang, Xinrui Weng, Le Ou-Yang
openaire   +2 more sources

Small-molecule affinity chromatography coupled mass spectrometry for drug target deconvolution

Expert Opinion on Drug Discovery, 2009
Current drug discovery organizations have renewed interest in phenotypic/function based screening for the identification of novel small-molecule drug candidates. Phenotypic screening faces the challenge of deconvoluting the identity of molecular targets of small-molecules through which they exert their biological effect.
Chaitanya, Saxena   +3 more
openaire   +2 more sources

GEFA: EARLY FUSION APPROACH IN DRUG-TARGET AFFINITY PREDICTION

Journal of Engineering Sciences
Predicting the interaction between a compound and a target is crucial for rapid drug repurposing. Deep learning has been successfully applied in drug-target affinity (DTA) problem. However, previous deep learning-based methods ignore modeling the direct interactions between drug and protein residues.
null B.VASANTHA   +3 more
openaire   +1 more source

Drug-Target Affinity Prediction Based on Topological Enhanced Graph Neural Networks

Journal of Chemical Information and Modeling
Graph neural networks (GNNs) have achieved remarkable success in drug-target affinity (DTA) analysis, reducing the cost of drug development. Unlike traditional one-dimensional (1D) sequence-based methods, GNNs leverage graph structures to capture richer protein and drug features, leading to improved DTA prediction performance. However, existing methods
Hengliang Guo   +11 more
openaire   +2 more sources

Drug-Target Affinity Prediction Based on Improved GraphDTA

2023 5th International Conference on Robotics and Computer Vision (ICRCV), 2023
Zi Ye   +3 more
openaire   +1 more source

MultiKD-DTA: Enhancing Drug-Target Affinity Prediction Through Multiscale Feature Extraction

Interdisciplinary Sciences: Computational Life Sciences
The discovery and development of novel pharmaceutical agents is characterized by high costs, lengthy timelines, and significant safety concerns. Traditional drug discovery involves pharmacologists manually screening drug molecules against protein targets, focusing on binding within protein cavities.
Riqian Hu   +5 more
openaire   +2 more sources

MFF-DTA: Multi-scale feature fusion for drug-target affinity prediction

Methods
Accurately predicting drug-target affinity is crucial in expediting the discovery and development of new drugs, which is a complex and risky process. Identifying these interactions not only aids in screening potential compounds but also guides further optimization.
Xiwei Tang   +3 more
openaire   +2 more sources

Prediction of drug-target binding affinity based on deep learning models

Computers in Biology and Medicine
The prediction of drug-target binding affinity (DTA) plays an important role in drug discovery. Computerized virtual screening techniques have been used for DTA prediction, greatly reducing the time and economic costs of drug discovery. However, these techniques have not succeeded in reversing the low success rate of new drug development.
Hao, Zhang   +4 more
openaire   +2 more sources

Contrastive Meta-Learning for Drug-Target Binding Affinity Prediction

2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), 2022
Mei Li   +4 more
openaire   +1 more source

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino   +2 more
exaly  

Home - About - Disclaimer - Privacy